Open AccessUSE OF THE NEW GENETIC ENGINEERING BIOLOGICAL AGENT TOCILIZUMABIN THE TREATMENT OF RHEUMATOID ARTHRITIS
Author(s) -
Е Л Насонов,
E. Panasyuk,
Е Л Насонов,
E. Panasyuk
Publication year - 2010
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2010-588
Subject(s) - tocilizumab , rheumatoid arthritis , medicine , joint disease , disease , biologic agents , clinical trial , tumor necrosis factor alpha , arthritis , pathology , alternative medicine , osteoarthritis